Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatases (PTPs) are a large family of enzymes that catalyze the removal of phosphate groups from phosphorylated tyrosine residues on proteins. This dephosphorylation is a key regulatory mechanism in eukaryotic cell physiology, affecting processes such as signal transduction, cell growth, proliferation, differentiation, transformation, and synaptic plasticity. Maintaining proper balance between protein tyrosine kinases (which add phosphates) and PTPs (which remove them) is crucial; dysregulation contributes to diseases such as cancer, diabetes mellitus type II/insulin resistance syndromes and autoimmune disorders.
Inhibition of protein tyrosine phosphatase activity, leading to increased tyrosine phosphorylation of target proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein Tyrosine Phosphatase (PTP).